Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed)
This funding opportunity seeks applications that use artificial intelligence and machine learning (AI/ML) to enhance drug discovery and preclinical drug development for Alzheimer's disease and related dementias. The aim is to speed up the identification and optimization of potential drug candidates, increasing their chances of success in clinical trials. Additionally, the program aims to creat…
This NOFO invites applications that apply existing or newly developed artificial intelligence and machine learning methods (AI/ML) to various aspects of drug discovery and preclinical drug development to accelerate the identification, optimization, and selection of preclinical drug candidates fo…
Funding Source
Awards & funding
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers